Comparison of primary and metastatic bladder tumors revealed higher rates of TP53 and TERT alterations in metastases, while RB1, KDM6A, and KMT2D mutations were more prevalent in primary tumors. The gene discussed is TERT; the disease is urinary bladder neoplasm.